• Price (CHF)37.62
  • Today's Change0.00 / 0.00%
  • Shares traded53.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 15 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Thursday, CompuGroup Medical SE & Co KgaA (COP:BRN) closed at 37.62, -5.60% below its 52-week high of 39.86, set on Jun 20, 2022.
52-week range
33.46Oct 03 202239.86Jun 20 2022
Short selling activity
Provided by S&P Global Market Intelligence
Previous close37.62
Average volume--
Shares outstanding53.73m
Free float26.71m
P/E (TTM)32.66
Market cap2.47bn EUR
EPS (TTM)1.41
Annual div (ADY)0.515
Annual div yield (ADY)1.37%
Div ex-dateMay 20 2022
Div pay-dateMay 24 2022
Data delayed at least 15 minutes, as of Dec 15 2022.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.